Clinical Trial Results: A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating rocatinlimab in combination with topical therapies for adults with moderate-to-severe atopic dermatitis; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Rocatinlimab (rocatinlimab)

Snippet

Sponsor: Amgen | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2026-08-06